PT Medikaloka Hermina Tbk Statistics
PT Medikaloka Hermina Tbk (HEAL) Stock Statistics & Valuation Metrics
Total Valuation
PT Medikaloka Hermina Tbk has a market cap or net worth of IDR 7.42T. The enterprise value is IDR 13.74T.
- Market Cap
- IDR 7.42T
- Enterprise Value
- IDR 13.74T
Share Statistics
PT Medikaloka Hermina Tbk has 15,365,950,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,365,950,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.96%
Financial Efficiency
PT Medikaloka Hermina Tbk’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 6.50%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 6.50%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 370.86M
- Profits Per Employee
- 22.33M
- Employee Count
- 19,235
- Asset Turnover
- 0.60
- Inventory Turnover
- 29.59
Valuation Ratios
The current PE Ratio of PT Medikaloka Hermina Tbk is 19.50. PT Medikaloka Hermina Tbk’s PEG ratio is -1.62.
- PE Ratio
- 19.50
- PS Ratio
- 0.99
- PB Ratio
- 1.31
- Price to FCF
- -92.91
- Price to Operating Cash Flow
- 5.13
- PEG Ratio
- -1.62
Income Statement
In the last 12 months, PT Medikaloka Hermina Tbk had revenue of 7.13T and earned 429.55B in profits. Earnings per share was 28.40.
- Revenue
- 7.13T
- Gross Profit
- 2.14T
- Operating Income
- 941.36B
- Pretax Income
- 754.88B
- Net Income
- 429.55B
- EBITDA
- 1.87T
- Earnings Per Share (EPS)
- 28.40
Cash Flow
In the last 12 months, operating cash flow was 1.43T and capital expenditures -1.51T, giving a free cash flow of -78.76B billion.
- Operating Cash Flow
- 1.43T
- Free Cash Flow
- -78.76B
- Free Cash Flow per Share
- -5.17
Dividends & Yields
PT Medikaloka Hermina Tbk pays an annual dividend of ―, resulting in a dividend yield of 2.76%
- Dividend Per Share
- ―
- Dividend Yield
- 2.76%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.08%
- Earnings Yield
- 5.15%
Stock Price Statistics
- Beta
- 0.60
- 52-Week Price Change
- -66.67%
- 50-Day Moving Average
- 596.60
- 200-Day Moving Average
- 920.57
- Relative Strength Index (RSI)
- 38.66
- Average Volume (3m)
- 16.07M
Important Dates
PT Medikaloka Hermina Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Medikaloka Hermina Tbk as a current ratio of 1.22, with Debt / Equity ratio of 56.82%
- Current Ratio
- 1.22
- Quick Ratio
- 1.13
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- 1.33
- Interest Coverage Ratio
- 3.95
Taxes
In the past 12 months, PT Medikaloka Hermina Tbk has paid 205.92B in taxes.
- Income Tax
- 205.92B
- Effective Tax Rate
- 0.27
Enterprise Valuation
PT Medikaloka Hermina Tbk EV to EBITDA ratio is 5.67, with an EV/FCF ratio of -130.96.
- EV to Sales
- 1.40
- EV to EBITDA
- 5.67
- EV to Free Cash Flow
- -130.96
- EV to Operating Cash Flow
- 7.22
Balance Sheet
PT Medikaloka Hermina Tbk has IDR 628.77B in cash and marketable securities with IDR 3.63T in debt, giving a net cash position of -IDR 3.00T billion.
- Cash & Marketable Securities
- IDR 628.77B
- Total Debt
- IDR 3.63T
- Net Cash
- -IDR 3.00T
- Net Cash Per Share
- -IDR 195.03
- Tangible Book Value Per Share
- IDR 471.44
Margins
Gross margin is 30.81%, with operating margin of 11.93%, and net profit margin of 5.11%.
- Gross Margin
- 30.81%
- Operating Margin
- 11.93%
- Pretax Margin
- 9.32%
- Net Profit Margin
- 5.11%
- EBITDA Margin
- 24.70%
- EBIT Margin
- 12.25%
Analyst Forecast
The average price target for PT Medikaloka Hermina Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.59%
- EPS Growth Forecast
- -11.98%
